8071 - 8080 of 8808 Results
Title
Year
-
OPENTitle: Pre-symptomatic Parkinson’s disease blood test quantifying repetitive sequence motifs in transfer RNA fragmentsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43587-025-00851-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12092246Citation Count: 3
-
OPENTitle: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's diseaseJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 133Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12483Best OA location URL: http://www.scopus.com/inward/record.url?scp=84941312569&partnerID=8YFLogxKCitation Count: 26
-
OPENTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Citation Count: 129
-
OPENTitle: Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom OnsetJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 3Start Page: 207End Page: 207Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13030207Best OA location URL: https://www.mdpi.com/2073-4409/13/3/207/pdf?version=1706001350Citation Count: 2
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
-
OPENTitle: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasetsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 38Issue #:Start Page: 103405End Page: 103405Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103405Citation Count: 33
-
OPENTitle: 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseasesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3477End Page: 3494Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa276Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3477/36134848/awaa276.pdfCitation Count: 144
-
RESTRICTEDTitle: Response to letter to the Editor: The association between cigarette smoking and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107895End Page: 107895Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107895Citation Count: 0
-
RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0